Talkspace, Inc.

NASDAQ:TALK

Medical - Care Facilities

Healthcare
$5.25 +0.19%

+$0.01 today

Market cap
$879.44M
Beta
1.07
P/E (TTM)
749.9
EPS (TTM)
$0.01
52W Low $2.22High $5.23

Volume 2.41M

Average 2.55M

TALK Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Talkspace, Inc.NASDAQ: TALK

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation growth accelerates

Q1 FY2026 stock-based compensation of $2.96M rose 26.8% year over year, ahead of the -157.3% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 54.4% from the prior quarter. Over 3 fiscal years it compounded at -11.3% a year.

Context

  • Stock-based compensation amounted to 3.7% of revenue in FY2025, down 1.2 pp from a year earlier.
  • Stock-based compensation increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +26.8% holds above the trailing-twelve-month pace of -157.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.96M+54.4% QoQ
Last fiscal yearDec 2025
$8.45M-7.9% YoY
LTMMar 2026
-$5.31M-157.3% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+26.8%——
1 year-7.9%——
3-year CAGR-11.3%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
8.45M USD
Year-over-year change
-7.9%
4-year CAGR
-25.5%

Stock-Based Compensation vs competitors

How TALK compares with its peers on the latest reported figures

  • TALK's LTM Mar 2026 stock-based compensation of $5.31M is the 8th largest of the 11 companies compared; the peer median is $6.54M.
  • Its year-over-year change of -157.3% is the lowest of 8, against a peer median of -10.7%.
  • Stock-based compensation amounts to 2.2% of revenue for TALK, versus a peer median of 1.7%.
TALK Competitors Peer median
Stock-Based Compensation for TALK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RIGLRigel Pharmaceuticals, Inc.LTM Mar 2026$12.84M +21.4%+0.9%4.3%
CMPSCOMPASS Pathways plcLTM Mar 2026$12.55M -31.5%+1.2%—
AVNSAvanos Medical, Inc.LTM Mar 2026$12.5M -10.7%-7.5%1.7%
CLPTClearPoint Neuro, Inc.LTM Mar 2026$8.49M +16.1%+25.6%20.9%
AIRSAirSculpt Technologies, Inc.LTM Mar 2026$6.61M -43.9%-57.1%4.4%
SNDASonida Senior Living, Inc.LTM Mar 2026$6.47M +35.8%+5.3%1.6%
KALVKalVista Pharmaceuticals, Inc.LTM Dec 2025$5.38M ——4.6%
TALKTalkspace, Inc.LTM Mar 2026$5.31M -157.3%-11.3%2.2%
INNVInnovAge Holding Corp.LTM Mar 2026$3.36M -56.6%+26.8%0.4%
CYHCommunity Health Systems, Inc.LTM Mar 2026$3M ——0.0%
NNNNAnbio Biotechnology Class A Ordinary SharesFY2025$0 ——0.0%
Peer median (excluding TALK) $6.54M-10.7%+1.2%1.7%

Competitors are the stored peer set for TALK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(62.74M)(79.67M)(19.18M)1.15M(5.22M)
Depreciation & Amortization1.97M1.36M1.2M859K2.88M
Deferred Income Tax(31.78M)0000
Stock-Based Compensation27.41M12.12M8.4M9.17M8.45M
Change in Working Capital(738K)2.12M(7.55M)895K(8.23M)
Accounts Receivables402K(4.13M)(534K)531K(6.42M)
Inventory(3.66M)0000
Accounts Payables503K(968K)(350K)1.6M791K
Other Working Capital2.01M7.21M(6.67M)(1.24M)(2.6M)
Other Non-Cash Items175K3M748K(371K)10.66M
Operating Cash Flow(65.71M)(61.08M)(16.39M)11.7M8.53M
Capital Expenditures(663K)(350K)(151K)(5.44M)(10.64M)
Acquisitions (Net)033K10K0(4.9M)
Purchases of Investments000(41.12M)(49.34M)
Sales of Investments000036.08M
Other Investing Activities000(171K)(10.71M)
Investing Cash Flow(663K)(317K)(141K)(46.73M)(28.88M)
Debt Repayment00000
Common Stock Issued251.43M3.18M2.71M2.01M913K
Common Stock Repurchased000(11M)(17.2M)
Dividends Paid00000
Other Financing Activities(50K)(1.5M)(810K)(1.19M)(2.71M)
Financing Cash Flow251.38M1.68M1.9M(12.19M)(19M)
Effect of Forex Changes00000
Net Change in Cash185.01M(59.71M)(14.64M)(47.22M)(39.34M)
Free Cash Flow(66.37M)(61.43M)(16.54M)6.26M(2.11M)

Talkspace, Inc.

NASDAQ:TALK

Intrinsic Alpha fair value

Locked

Current Price

$5.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.